Loading...
Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
INTRODUCTION: Biological disease-modifying antirheumatic drugs are particularly recommended for use in patients who are poor responders, are intolerant to conventional disease-modifying antirheumatic drugs (cDMARDs), or in whom continued treatment with cDMARDs is deemed inappropriate. We estimated t...
Na minha lista:
| Udgivet i: | Clinicoecon Outcomes Res |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5525457/ https://ncbi.nlm.nih.gov/pubmed/28765712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S141610 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|